Document dYea7eE1KkkpOzNdK5e9Vmone

RISK MANAGEMENT OF EXISTING CHEMICALS Proceedings of a Seminar Conducted December 8-9, 1983 Washington, D.C. Sponsored by: Chemical Manufacturers Association AP00055161 CONTENTS Foreword J. Ronald Condray Monsanto Company Executive Summary State-of-the-Art of Risk Management Presentation Highlights Overview Role of Risk Assessment at Chemical Manufacturers Association Dr. Jerry M, Smith Rohm and Haas Company Introduction The Evolving "Existing Chemicals Program": An Introduction to the Seminar Dr. Fred D. Hoerger The Dow Chemical Company CHAPTER 1 Science and Policy in Risk Control Dr. J. Clarence Davies Conservation Foundation Inc. CHAPTER 2 Industry's Perspective on How Risk Management Is Working Deems Buell Peat, Marwick, Mitchell Sc Company IV vu 11 13 22 AP00055162 ent sal ?rogram'': vii 1 9 11 Management y 13 22 CHAPTER 3 Toxic Substances Control Act: New Attitudes, New Directions Dr. John A. Moore Environmental Protection Agency 33 CHAPTER 4 Quantitative Risk Assessment: State-of-the-Art for Carcinogenesis Dr. Colin N. Park, Dow Chemical U.S.A. Dr. Ronald D. Snee, E,I. du Pont de Nemours & Company 36 CHAPTER 5 Government Data Requirements for Risk Assessment Dr. Joseph V. Rodricks Environ Corporation 80 CHAPTER 6 Utilization of Risk Assessment in Corporate Risk Management Decisions Dr. Paul F. Deisler, Jr. Shell Oil Company 91 CHAPTER 7 Remarks to the Chemical Manufacturers Association Senator David Durenberger Committee on Environment and Public Works 111 CHAPTERS Industrial Viewpoint and Case Histories Dr. Calvin J. Benning Essex Chemical Corporation 119 CHAPTER 9 A Case History--Phthalates Section 4 Test Data Use in Regulatory Control Decisions Dr. James P. Mieure Monsanto Company 121 v AP00055163 CHAPTER 10 Vinyl Chloride and TSCA John T. Barr Air Products & Chemicals, Inc. CHAPTER 11 Industry's Perspective ort How Industry/Government Risk Management Partnership Can Work Dr. John D. Behun Mobil Oil Corporation CHAPTER 12 TSCA's Role in the Overall Federal Regulatory Scheme Robert M. Sussman, Esquire Covington and Burling CHAPTER 13 Use of Quantitative Risk Assessment in Regulatory Decisionmaking Under Federal Health and Safety Statutes Peter Barton Hutt, Esquire Covington and Burling Conclusions Summary Carl W. Urnland Exxon Chemical Americas Wrap Up Comments J. Ronald Condray Monsanto Company 129 143 158 166 181 183 vi AP00055164 IG CHEMICALS mal effect levels for subnnogenicity. In each ease, ily intake" implies a regula- values are acceptable to ?nts of animal carcinogens, OSHA, and EPA have all v one in a million ought not 'es these values represent isions on phthalate esters. Is should not be regulated, nay need to be subjected to there is a significant popujse principles to regulatory 1 program. Idvisory. "Review of Data erning Formaldehyde and uary 12, 1982. ry Toxicology and Pharroaess). CHAPTER 10 VINYL CHLORIDE AND TSCA John T. Barr Air Products and Chemicals, Inc. INTRODUCTION The well-known regulatory history of vinyl chloride and its role as a bellwether of current regulatory philosophy makes It a useful paradigm for examining the relationship of existing laws and the Toxic Substances Control Act (TSCA) for control of chronic hazards. To this end, we will first review some of the highlights of its regulatory history, and then engage in some speculation as to the response these events might elicit today under TSCA. INDUSTRIAL AND COMMERCIAL USE OP VINYL CHLORIDE Vinyl chloride became of industrial importance about fifty years ago, approximately a hundred years after its discovery, when Semons discovered that its polymer could be converted into useful articles by plastization with phthalate esters. Commercial develop ment began first in Europe and then in this country In the late 1/ Air Products and Chemicals, Inc., 1983. 129 AP00055165 130 / RISK MANAGEMENT OF EXISTING CHEMICALS thirties, largely using existing rubber processing equipment, for it was rubber which it initially replaced in the market. For the same reason, the use of polyvinyl chloride (PVC) was sequestered by the government during the war years, and it was not until the early fifties that widespread consumer applications developed. PVC is now a mature product, and its growth rate falls in step with the Gross National Product. Presently, about six billion pounds are used annually in this country, and about four times that in the world. Some of the broader toxicological attributes of vinyl chloride (VC) were recognized in the thirties. It was known to be an anes thetic, but problems with cardiac arrythmia prevented its use in that application.2^ As pathological techniques improved, industry scien tists recommended in the early sixties that exposure be limited to 50 ppm, because of temporary liver enlargement in animals at that level, ' but the American Conference of Governmental and Indus trial Hygienists considered this overly conservative and accepted instead the 500 ppm recommendation of Harvard scientists.4^ This was the value adopted by the Occupational Safety and Health Administration (OSHA) in its formative days. Also in the early sixties, the European industry recognized among its workers a disease termed aeroosteolysis, AOL, which is a degenerative disease of the bone tufts, particularly in the fingers, that is accompanied by Reynaud's phenomenon.^ An extensive epi- I 2/ W. F. von Oettlgin, "The Halogenated Hydrocarbons, Their Toxicity and Potential Dangers," Public Health Service Publication No, 414 (Washington, D.C.: U.S. Department of Health, Education and Welfare, 1955). 3/ T. R. Torkelson, F. Oyers, and V. K. Rowe, "The Toxicity of VC as Determined by Repeated Exposures of Laboratory Animals," American Industrial Hygiene Association Journal. XXII (1961), p, 354. 4/ American Conference of Governmental and Industrial Hygien ists, "Documentation of the Threshold Limit Value, 1963" (Cincin nati, OH, 1963). 5/ S. Suciu, J. Drejman, and M. Valaskai, "Study of Diseases Caused by Vinyl Chloride," Medical Intern., XV (1963), p. 967. AP00055166 IG CHEMICALS recessing equipment, for it the market. For the same VC) was sequestered by the it was not until the early lations developed. PVC is rate falls in step with the t six billion pounds are used imes that in the world, attributes of vinyl chloride : was known to be an anesnia prevented its use in that ;s improved, industry scienthat exposure be limited to rgement in animals at that -f Governmental and Indusconservative and accepted Harvard scientists.^ This ational Safety and Health ays. ropean industry recognized >osteoiysis, AOL, which is a particularly in the fingers, nenon.57 An extensive epi lated Hydrocarbons, Their Health Service Publication :ment of HeaLth, Education Rowe, "The Toxicity of VC ; of Laboratory Animals," 'n Journal, XXII (1961), p, ntal and Industrial Hygien- ..imit Value, 1963" (Cincin- askai, "Study of Diseases Ty XV (1963), p. 967. VTNYL CHLORIDE / 131 demiological survey here and in Europe found about a hundred possi ble cases which were associated closely with manual cleaning of reactor walls between polymerization batches, but neither the pre cise etiological agent nor the disease mechanism was identified. ' An attempt was made to reproduce this disease in rats by the medical department of one of the European producers. An exact duplication of the human disease was not seen, but many of the rats developed tumors at numerous sites. The reporting of this finding by Viola7' in 1970 evoked little interest in the regulatory community, possibly because of the very high doses used, several thousand ppm, which were frankly toxic to the animals, and the fact that the tumors were largely metastatic from the Zymbal gland, an organ not present in humans. Nevertheless, both the European and domestic producers formed consortia to perform bioassays at lower concentrations and also began epidemiological surveys of their employees. Preliminary results of the European bioassay became available first in early 1973, and showed tumor development at much lower concentrations in organs which do have human counterparts. This result was transmitted to regulatory officials that summer, and industry screening of employee records was intensified.^ This re sulted in the recognition that winter by an industry medical director of a cluster of three rare liver tumors termed angiosarcoma, ASL, in the employees of one facility.The reporting of this fact to >/ W. A. Cook, et aL, "Industrial Hygiene Evaluation of Thermal Degradation Products from PVC Fetus in Meat-wrapping Opera tions," Arch. Environ. Health. XXII (1971), p. 74. Also, B. D. Diman, 7t ah, "Occupational Acroosteolysis I, An Epidemiological Study," bid., p. 61. 7/ P. L. Viola, "Pathology of Vinyl Chloride," Medictrta del Lavoro. LXI (1970), p. 174. V A. W. Barnes, "ICI Ends Its Silence on Vinyl Chloride," Chemical Engineering News. (July 8, 1974), p. 21. 9/ J. L. Creech and M. N. Johnson, "Angiosarcoma in Workers Ex posed to Vinyl Chloride as Predicted for Studies in Rats," Journal of Occupational Medicine. XVI (1974), p. 150. AP00055167 132 / RISK MANAGEMENT OF EXISTING CHEMICALS government officials led to the current regulatory status of vinyl chloride. It also led to a virtual explosion of research on the chronic toxicity of VC. The body of scientific literature on the oncogenicity of vinyl chloride is as large as that for any other substance. It is recognized that VC is a classical procarcinogen. Metabolism by the mixed function oxidase in the liver converts it to the ultimate car cinogen, an epoxide. Detoxification of this intermediate by the sulfhydryl group of glutathione or other proteins removes the toxic potential. ^ Both of those mechanisms are saturable.11/f An over load of the metabolic step assures that the vinyl chloride will pass through the liver and some will be metabolized in other organs. An overload of the detoxification step allows escape of the toxicant into the sinusoidal passages of the liver where interaction with the chromosomal protein causes ASL to develop. An overload of both mechanisms can lead to tumor development outside of the liver, as is seen in mice and rats at very high doses. Despite the large data base, however, information on the precise mechanism of these vari ous steps still is lacking. We do not even understand why some per sons respond with AOL and some with ASL, but none with both diseases. OSHA proceeded promptly in early 1974 to set an emergency temporary limit of 50 ppm for worker exposure, and later that year reduced the limit to one ppm, the current figure. Industry was given a grace period during which respirators could be used to meet this requirement, but now that level must be met by engineering prac tices.12' AP00055168 CHEMICALS VINYL CHLORIDE / 133 egulatory status of vinyl ' research on the chronic ature on the oncogenicity ny other substance. It is iogen. Metabolism by the ts it to the ultimate carthis intermediate by the oteins removes the toxic e saturable. An overe vinyl chloride will pass lized in other organs. An 5 escape of the toxicant here interaction with the op. An overload of both it outside of the liver, as Despite the large data mechanism of these varitnderstand why some per1SL, but none with both 974 to set an emergency osure, and later that year igure. Industry was given iuld be used to meet this net by engineering prac- The Environmental Protection Agency (EPA) promulgated a combined engineering and works practice standard in 1976 which has resulted in ambient concentrations in the fractional ppb range near producing or using facilities.13^ In the meanwhile, the Food and Drug Administration (FDA) and Consumer Product Safety Commission (CPSC) established prohibi tions on the use of VC in aerosol or other consumer applications, a practice which had been discontinued in 1973. The Bureau of Alcohol, Tobacco and Firearms of the Treasury Department (BATF) had already banned the use of PVC liquor bottles in 1973 because of concern for taste effects from migration of residual VC into the contents. In 1975 the FDA proposed revocation of the generally regarded as safe (GRAS) status of rigid PVC packaging under the Delaney clause, also because of migration concerns, but that proposal never has been promulgated, and the FDA has stated that it ;s considering withdrawal of the proposal and recommending to BATF the reauthorization of plastic liquor bottles in light of the current very low residual monomer levels in fabricated PVC articles. Other regulations have followed as new statutes and rules have come into play. The Department of Transportation (DOT) and the Coast Guard regulate the transportation of VC, of course, and VC is iisted as a priority pollutant and hazardous waste under various water and solid waste rules, and has a reportable quantity of one pound under Superfund. Did the existing laws operate satisfactorily at the time of liscovery of the chronic hazards of VC? It appears that they did. A heading medical authority who was deeply involved in the worker health evaluation in 1974 has termed VC a "success story." Reeval-'.ation of the risk to employees under the one ppm standard by a conservative nonthreshold extrapolation method**' yields a lifetime estimate of less than LQ"8, a risk level which is not thought to be of concern. The comparable risk estimate for the general populace is .*r, "Advance in Internal '<LVII (New York, 1981). iring, "Percutaneous AbMonkey," Toxicology and 3. CFR 1910.1017. 1 13/ EPA Standard for Vinyl Chloride, 40 CFR 61.60. i f 14/ P. J. Gehring, P. G. Watanabe, and C. N. Park, "Risk of Angio! sarcoma in Workers Exposed to Vinyl Chloride as Predicted for Stud5 ies in Rats," Toxicology and Applied Pharmacology," XLIX (1979), p. 15. i i I AP00055169 134 / RISK MANAGEMENT OP EXISTING CHEMICALS several orders of magnitude lower. EPA has stated on several occasions that it believes that vinyl chloride is regulated adequately. RISK ASSESSMENT Risk assessment has been a popular avocation among those interested in VC, and more than a dozen have been performed.*5^ These can be divided generally into two classes: those which rely solely on animal data; and those which attempt to incorporate the human experience. Those in the first class yield similar results, and show the normal spread of estimates from the various mathematical models in common use. These range from 1,500 to 1Q"5 ppb for a lifetime risk of 10", or eight orders of magnitude. It is necessary to eliminate the high-dose data points, that is, those over 2,500 ppm from the Maltoni data16^ in order to get reasonable fits to most models, because these doses show broad systemic toxicity. The lower doses, 500 ppm and below, as a group fall into a general pattern on a logprobit plot, but individual two or three dose experiments show tre mendous differences in slope when plotted separately. The popular multihit model predicts a lifetime risk of 10" at fractional ppb levels. The human factor was accounted for in two ways. The EPA used some preliminary employee epidemiological data to confirm its animal-based extrapolation. Unfortunately, the human data were 15/ J. T. Barr, "Risk Assessment for Vinyl Chloride in Perspec tive," (Paper 82-9.2 presented at the 75th Annual Meeting of the Air Pollution Control Association, New Orleans, LA, 1982), Lines 2025. 16/ C. Maltoni, et al., "Vinyl Chloride Carcinogenicity Bioassays (BT Project)," (Paper presented at "Le Club de Cancerogenese Chemique," Institute Curie, Paris, November 10, 1979). 17/ A. M. Kusmeck and R. E. McGoughy, "Quantitative Risk Assessment for Community Exposure to Vinyl Chloride," (Washing ton, D.C.: U.S. Environmental Protection Agency, December 5, 1975). AP00055170 CHEMICALS \ has stated on severaL is regulated adequately. avocation among those have been performed. ' lasses: those which rely tempt to incorporate the ir results, and show the 5 mathematical models in r3 ppb for a lifetime risk is necessary to eliminate over 2,500 ppm from the ole fits to most models, oxicity. The lower doses, general pattern on a logse experiments show trei separately. The popular sf 10"6 at fractional ppb r in two ways. The EPA iogical data to confirm its tely. the human data were inyl Chloride in Perspecth Annual Meeting of the leans, LA, 1982), Lines 20- Carcinogenicity Bioassays : Club de Cancerogenese )er 10, 1979). >ughy, "Quantitative Risk Vinyl Chloride," (Washing ton Agency, December 5, VINYL CHLORIDE / 135 selected from those locations known to have ASL cases, while other facility data were omitted. They also were in error on the past exposures by more than an order of magnitude. This resulted in an estimate of 20 cases per year from the estimated 1974 ambient concentrations for the population within five miles of production and processing facilities. The EPA seldom bothers to cheek its estimates against avail able data, so it sometimes comes up with results such as that made for arsenic a few years ago that would have predicted 18 million cases of skin cancer a year in this country if it had been applied to Agency data on the average arsenic concentrations in drinking water. Similarly, a survey of all known ASL eases in this country for :he ten years before 1974 showed no cases associated with residency near such plants,^ rather than the 200 predicted cases. It is rea sonable to assume that if any cases had developed since that time, the publicity associated with it would have brought them to light. Thus we have 110 million-person years of negative history for nearby residents. This places an upper limit on risk of less than 10"*^ per ?pm-yr. Two studies applied pharmacokinetics in an attempt to obtain relevant human data. Gehring and eoworkers estimated a lifetime risk of 10-8 at one ppm from the probit model, based on a biotrans formation of rat data. The unconstrained linear model predicted no risk at less than 99 ppm.*9^ Anderson, Hoel and Kaplan carried this procedure one step further, and applied it to bound metabolic products, rather than to :he_total amount metabolized. Their results gave a lifetime risk of 10"' at less than one ppm, with the probit model, or at less than two ppm with the linearized multistep model.^ r 13/ H. Popper, et aL, "Development of Hepatic Angiosarcoma in Man Induced by Vinyl Chloride, Thorotrast, and Arsenic,11 American { "ournal of Pathology, XCII (1978), p. 349. 19/ p. J. Gehring, P. G. Watanabe, and C. N. Park, Toxicology and Applied Pharmacology, XLIX (1979), p. 15. 29/ M. W. Anderson, D. G. Hoel, and N. L. Kaplan, "A General Scheme for the Incorporation of Pharmacokinetics in Low-dose Risk Estimation for Chemical Carcinogens, ibid., LV (1980), p. 154. i AP00055171 136 / RISK MANAGEMENT OP EXISTING CHEMICALS Thus we see that risk is in the eye of the estimator, but it is clear that estimates incorporating human data reflect the human experience for VC far better than do the direct application of ani mal data. There was understandable uncertainty on the part of both the regulators and industry in 1974. This was the first commodity chem ical to be regulated under the relatively new statutory situation as the result of new information. Nevertheless, both the regulatory agencies and industry acted promptly to reduce exposures and emis sions to an acceptable level. The current count of occupational ASL cases is about 100 worldwide, with 30 of these in this country.2^ AU these cases had their first exposure in 1964 or earlier, and there appears to be room for optimism that the steps taken in the mid-sixties because of the AOL information will have prevented any significant number of cases developing from exposures commencing after that date. Cer tainly it is reasonable to expect that there have been no new cases initiated after the early seventies. Had TSCA been in plaee in the mid-sixties, would it have made any difference in the course of events? It appears unlikely that it would. Certainly the AOL discovery would have resulted in a series of 3(e) notices to TSCA. The probable outcome of that would have been either a recommendation from the Interagency Testing Com mittee (ITC) for more tests, or a Section 4 testing requirement. It is possible that, because of its commercial importance, VC could have been placed on the ITC list before the AOL data became available. Additional data could have been called for under Sections 8(a) and (d). The result of all this most likely would have been a negotiated testing rule, under which industry would have initiated a series of studies which would have culminated in a bioassay, and the car cinogenicity of VC would have been discovered in due time. Yet, this is precisely what did happen in the absence of TSCA, except that the preliminaries were omitted, and the bioassay was performed concurrently with the screening tests. Thus it is possible that the 21/ J. Stafford, personal communication. Liver Angiosarcoma Cases, April 15, 1983. AP00055172 1 CHEMICALS the estimator, but it is i data reflect the human direct application of ani- y on the part of both the he first commodity chemtew statutory situation as 5less, both the regulatory iduce exposures and emis- ASL cases is about 100 All these cases had . there appears to be room mid-sixties because of the ny significant number of ring after that date, Cer*e have been no new cases ixties, would it have made It appears unlikely that it d have resulted in a series itcome of that would have Interagency Testing Corntesting requirement. It is importance, VC could have 3L data became available, or under Sections 8(a) and ild have been a negotiated have initiated a series of a bioassay, and the carovered in due time. Yet, absence of TSCA, except oe bioassay was performed hus it is possible that the ion, Liver Angiosarcoma VINYL CHLORIDE / 137 final critical data were obtained earlier than would have occurred under present conditions. Bear in mind that most of today's powerful testing methods were not available twenty years ago. That fact would not have been changed by legislative fiat, and any decision made at that time had to be made in light of the available knowledge. If the data of Viola suddenly became available today instead, would there be any significant difference in the outcome, or the timing of that outcome? Probably so, but only because of the vastly more powerful scientific tools which we have available to us now. Neither the speed of agency motion nor the rate at which industrial facilities can be built or modified has increased. If anything, the Latter has slowed, given the multiplicity of permits and approvals now required. Overall, it is possible that if today we knew nothing more about VC than was known in 1970, we would arrive at a regu lated state a few months earlier than was achieved in 1974, but scientific progress, and not legislative or regulatory advancement, mould get the credit. What if VC were to become a new product today? Would it run the same course in which it would be 40 years before there was full recognition of its chronic potential? Certainly not. Again, however, :he reason is due more to scientific progress rather than statutory development. One change might be apparent. If VC were the subject of a Premanufacture Notification (PMN) today, rather than being the model to which all other aliphatic olefins are compared for struc`.ure-activity analysis, it would be judged by the others In its family. This comparison would be less dogmatic than the reverse is now. Ethylene and vinylidene chloride are not animal carcinogens; the relevance to humans of the carcinogenicity of high doses of trichloroethylene (TCE) is equivocal and controversial; and vinyl acetate has only a preliminary "non-negative" report. Thus, this class of substances would have lost its leader for structure activity comparison, and a decision as to the need for further testing from that analysis would not be clear-cut, based on analogous compounds. Neither would a full minimum premanufaeture data (MPD) set be of any great assistance. VC responds poorly to the classical invitro tests, and only recently has it become possible to obtain repro ducible positive results in many of these. If the position were taken i i i i AP00055173 138 / RISK MANAGEMENT OF EXISTING CHEMICALS that any positive result triggers further testing, then we would be left exactly where we were in the late sixties, recognizing the need for a bioassay. One other point should be considered before the requirements of Section 9 of TSCA to give primacy to existing statutes is ignored. Section 2 of TSCA requires the consideration of economic factors in actions taken under TSCA, while the Occupational Safety and Health Act and the Clean Air Act Section 112 do not. In fact, at the time that VC was being regulated, these two statutes were being interpreted as forbidding economic consideration. Had TSCA been the regulatory vehicle of 1974, it is unlikely that the final reg ulations could have been as strict as they actually became, because of this factor. It is difficult to separate cleanly the compliance costs for the OSHA and EPA rules on VC because of the overlapping time periods. The best estimate for OSHA costs made by the industry in a presentation to the Presidential Task Force on Regulatory Relief was something over $200 million of capital, with over $25 million per year of annual costs. The EPA has reported to Congress^/ that compliance with its rule has cost about $100 million per year since 1978. Thus, about $900 million has been expended thus far. Various published costs per life saved have ranged from $4 to $200 million for the OSHA standard, depending on which exposure starting point was used. The more costly EPA standard appears not to have pre vented any cases of ASL, based on epidemiology, and thus has an infinite cost.^/ This suggests that the proponents of strong TSCA activity for existing chemicals should reconsider their position on Section 9 If their long-term goal is more stringent regulations. There seems to be no sure method of preventing some surprises in toxicology. Improved surveillance and diagnostic methods assure that we will know more about chronic effects in the future than we do now. New substances simply cannot be subjected to full-scale AP00055174 HEMICALS ting, then we would be is, recognizing the need efore the requirements existing statutes is igsideration of economic he Occupational Safety on 112 do not. In fact, bese two statutes were nsideration. Had TSCA ikely that the final regtually became, because ompliance costs for the the overlapping time made by the industry in e on Regulatory Relief . with over $25 million ted to Congress^/ that ) million per year since ended thus far. Various rom $4 to $200 million exposure starting point jpears not to have preiology, and thus has an jonents of strong TSCA isider their position on igent regulations, eventing some surprises gnostic methods assure :s in the future than we subjected to full-scale -} Cost of Clean Air and enate Document 96-38, hloride in Perspective." VINYL CHLORIDE / 139 testing before they show strong commercial promise, tf there were no other reasons for this, the limitation on test facilities dictates that we direct our immediate effort toward substances of major Import, and this is being done at capacity. It is proper that we con centrate our efforts on present exposures. Fortunately, recent med ical advances help us to recognize these surprises earlier, and to ninimize their impact. Existing statutes, that is, non-TSCA derived regulations, appear to be able to regulate existing substances adequately. The history of vinyl chloride bears this out. The principal value of the TSCA derived activities seems to be in the gathering of surveillance data on these substances to assure that the relevant data are made available to the proper agencies, and in future oversight of new substances as they develop into commercial items. JUMMARY AND CONCLUSIONS The reexamination of the hazards of all existing chemicals is m overwhelming task for which EPA has no special expertise.^4/ Just the establishment of priorities for such a reexamination is jeyond the present capacity of the Agency.^^ The Agency has ecognized some of the problems which it faces, and the recent "TSCA Priorities and Progress, 1983" report discusses a much more :harplv delineated existing chemicals program. Even here, however, :he division between TSCA and existing statutes is not defined nearly. Further, the Agency appears to be entering the realm of 'i'k management through its Advisory and Chemical Hazard Infor mation Profile (CHIPs) series. One unfortunate result of this is the jeneration of another tainted list of substances which becomes an invitation for pressure to regulate. The temptation to prepare these '--3/ National Research Council, "Regulating Pesticides," (Washing.jn, D.C.: Environmental Studies Board, Committee on National { Resources, 1980). i -5/ J. T. Barr, "Establishing Regulatory Priorities," Toxic Sub stances Journal, IV (1983), p. 290. s j! i: AP00055175 140 / RISK MANAGEMENT OF EXISTING CHEMICALS "little lists" for the executioners apparently is too gTeat to be re sisted,26^ as Lester Lave pointed out recently. We believe that EPA can best obey its statutory mandate by developing a more efficient system for establishing priorities, and by implementing more effectively its Section 9 procedures. BIBLIOGRAPHY American Conference of Governmental and Industrial Hygienists. "Documentation of the Threshold Limit Value, 1963." Cincinnati, OH, 1963. Barnes, A. W. 'TCI Ends its Silence on Vinyl Chloride." Chemical Engineering News, (July 8, 1974), 21. Barr, J. T. "Risk Assessment for Vinyl Chloride in Perspective." Paper 82-9.2, 75th Annual Meeting of the Air Pollution Control Association, New Orleans, LA (1982). Barr, J. T. "Establishing Regulatory Priorities." Toxic Substance Journal, VoL IV (1983), 290. Cook, W. A. "Industrial Hygiene Evaluation of Thermal Degradation Products from PVC Fetus in Meat-wrapping Operations." Arch. Environ. Health, VoL XXII (1971), 74. Creech, J. L., and Johnson, M. N. "Angiosarcoma of Liver in Manu facture of PVC." Journal of Occupational Medicine XVI (1974), 150. AP00055176 riEMICAlS is too great to be re3 statutory mandate by .ishing priorities, and by procedures. i Industrial Hygienists, lue, 1963." Cincinnati, L. "A. General Scheme cs in Low-dose Risk oxicologv and Applied /I Chloride." Chemical loride in Perspective." Air Pollution Control ities." Toxic Substance i( Thermal Degradation ig Operations." Arch. coma of Liver in Manu-dicine XVI (1974). 150. ating Low Risks," Wall VINYL CHLORIDE / 141 Diman, B. D., et al. "Occupational Acroosteolysis I, An Epidemio logical Study." Arch. Environ. Health, Vol. XXH (1971), 6L. Environmental Protection Agency. "The Cost of Clean Air and Clean Water." Annual Report to Congress, Senate Document 96-38, December, 1979. Gehring, P. J., Watanabe, P. G., and Park, C. N. "Risk of Angio sarcoma in Workers Exposed to Vinyl Chloride as Predicted for Studies in Rats." Toxicology and Applied Pharmacology, Vol. XLIX (1979), 15. Hefner, R.; Watanabe, P.jand Gehring, P. "Percutaneous Absorption of Vinyl Chloride Gas in Rhesus Monkey." Toxicology and Applied PharmacoLogy, Vol. XXXIV (1975), 529. Xusmack, A. M., and McGoughy, R. E. "Quantitative Risk Assess ment for Community Exposure to Vinyl Chloride." U.S. Environ mental Protection Agency, Washington, D.C.j December 5, 1975. Lave, L. "The High Cost of Regulating Low Risks." Wall Street Journal, August 19, 1983. Lelbach, W. K., and Marsteller, H. J. "Advance in Internal Medicine and Pediatrics." New York: Springer-Verlag, Vol. XLVII (1981). Maltoni, C., et al., "Vinyl Chloride Carcinogenicity Bioassays (BT , Project)." Paper presented at "Le Club de Cancerogenese Chemi que," Institute Curie, Paris, November 10, 1979. k ! National Research Council. "Regulating Pesticides." Environmental Studies Board, Committee on National Resources, Washington, D.C., 1980. Popper, H., et al. "Development of Hepatic Angiosarcoma in Man | Induced by Vinyl Chloride, Thorotrast, and Arsenic." American f Journal of Pathology, Vol. XCH (1978), 349. t j Stafford, J. Personal communication. Liver Ai^iosarcoma Cases, April 15, 1983. > i ! i i AP00055177 142 / RISK MANAGEMENT OP EXISTING CHEMICALS Suciu, S.: Drejman, J.; and Valaskai, M. "Study of Diseases Caused by Vinyl Chloride." Medical Intern. Vol. XV (1963), 967. Torkelson, T. R.; Oyers, F.; and Rowe, V. K. "The Toxicity of VC as Determined by Repeated Exposures of Laboratory Animals." Amer ican Industrial Hygiene Association Journal, Vol. XXII (1961), 354. Viola, P. L. "Pathology of Vinyl Chloride." Medicina del Lavoro. Vol. LXI (1970), 174. Von Oettigin, W. F. "The Halogenated Hydrocarbons, their Toxicity and Potential Dangers." Public Health Service Publication No. 414, U.S. Department of Health, Education and Welfare, Washington, D.C., 1955. AP00055178